172 related articles for article (PubMed ID: 32544163)
1. Analysis of the mutant selection window and killing of Mycoplasma hyopneumoniae for doxycycline, tylosin, danofloxacin, tiamulin, and valnemulin.
Huang Z; Mao C; Wei Y; Gu X; Cai Q; Shen X; Ding H
PLoS One; 2020; 15(6):e0220350. PubMed ID: 32544163
[TBL] [Abstract][Full Text] [Related]
2. Determination of the Mutant Selection Window and Evaluation of the Killing of Mycoplasma gallisepticum by Danofloxacin, Doxycycline, Tilmicosin, Tylvalosin and Valnemulin.
Zhang N; Ye X; Wu Y; Huang Z; Gu X; Cai Q; Shen X; Jiang H; Ding H
PLoS One; 2017; 12(1):e0169134. PubMed ID: 28052123
[TBL] [Abstract][Full Text] [Related]
3. In vitro susceptibilities of recent field isolates of Mycoplasma hyopneumoniae and Mycoplasma hyosynoviae to valnemulin (Econor), tiamulin and enrofloxacin and the in vitro development of resistance to certain antimicrobial agents in Mycoplasma hyopneumoniae.
Hannan PC; Windsor HM; Ripley PH
Res Vet Sci; 1997; 63(2):157-60. PubMed ID: 9429250
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic-pharmacodynamic integration and resistance of tiamulin against Mycoplasma hyopneumoniae in an in vitro dynamic model.
Huang Z; Xia X; Mao C; Gu X; Shen X; Yang H; Ding H
Microb Pathog; 2020 Oct; 147():104255. PubMed ID: 32407861
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial susceptibility monitoring of Mycoplasma hyopneumoniae isolated from seven European countries during 2015-2016.
de Jong A; Youala M; Klein U; El Garch F; Moyaert H; Simjee S; Maes D; Gyuranecz M; Pridmore A; Thomson JR; Ayling RD;
Vet Microbiol; 2021 Feb; 253():108973. PubMed ID: 33418394
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of tylvalosin against Spanish field strains of Mycoplasma hyopneumoniae.
Tavío MM; Poveda C; Assunção P; Ramírez AS; Poveda JB
Vet Rec; 2014 Nov; 175(21):539. PubMed ID: 25185108
[TBL] [Abstract][Full Text] [Related]
7. Macrolide-Resistance Selection in Tibetan Pigs with a High Load of Mycoplasma hyopneumoniae.
Qiu G; Rui Y; Zhang J; Zhang L; Huang S; Wu Q; Li K; Han Z; Liu S; Li J
Microb Drug Resist; 2018 Sep; 24(7):1043-1049. PubMed ID: 29271698
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic susceptibility testing of Mycoplasma hyopneumoniae field isolates from Central Europe for fifteen antibiotics by microbroth dilution method.
Felde O; Kreizinger Z; Sulyok KM; Hrivnák V; Kiss K; Jerzsele Á; Biksi I; Gyuranecz M
PLoS One; 2018; 13(12):e0209030. PubMed ID: 30533041
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo comparisons of valnemulin, tiamulin, tylosin, enrofloxacin, and lincomycin/spectinomycin against Mycoplasma gallisepticum.
Jordan FT; Forrester CA; Ripley PH; Burch DG
Avian Dis; 1998; 42(4):738-45. PubMed ID: 9876842
[TBL] [Abstract][Full Text] [Related]
10. Tiamulin resistance in porcine Brachyspira pilosicoli isolates.
Pringle M; Landén A; Franklin A
Res Vet Sci; 2006 Feb; 80(1):1-4. PubMed ID: 16253666
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic susceptibility profiles of Mycoplasma synoviae strains originating from Central and Eastern Europe.
Kreizinger Z; Grózner D; Sulyok KM; Nilsson K; Hrivnák V; Benčina D; Gyuranecz M
BMC Vet Res; 2017 Nov; 13(1):342. PubMed ID: 29149886
[TBL] [Abstract][Full Text] [Related]
12. Evaluation the kill rate and mutant selection window of danofloxacin against Actinobacillus pleuropneumoniae in a peristaltic pump model.
Wang H; Liao C; Ding K; Zhang L; Wang L
BMC Vet Res; 2024 Jun; 20(1):241. PubMed ID: 38831324
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial susceptibility monitoring of Mycoplasma hyopneumoniae and Mycoplasma bovis isolated in Europe.
Klein U; de Jong A; Moyaert H; El Garch F; Leon R; Richard-Mazet A; Rose M; Maes D; Pridmore A; Thomson JR; Ayling RD
Vet Microbiol; 2017 May; 204():188-193. PubMed ID: 28532800
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of tiamulin against porcine mycoplasmas.
Goodwin RF
Res Vet Sci; 1985 Jan; 38(1):124-5. PubMed ID: 3975477
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility to pleuromutilins in Brachyspira (Serpulina) hyodysenteriae.
Karlsson M; Gunnarsson A; Franklin A
Anim Health Res Rev; 2001 Jun; 2(1):59-65. PubMed ID: 11708748
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial susceptibility profiles of porcine mycoplasmas isolated from samples collected in southern Europe.
Rosales RS; Ramírez AS; Tavío MM; Poveda C; Poveda JB
BMC Vet Res; 2020 Sep; 16(1):324. PubMed ID: 32883288
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Minimum Inhibitory Concentrations for 154 Mycoplasma synoviae isolates from Italy collected during 2012-2017.
Catania S; Bottinelli M; Fincato A; Gastaldelli M; Barberio A; Gobbo F; Vicenzoni G
PLoS One; 2019; 14(11):e0224903. PubMed ID: 31697761
[TBL] [Abstract][Full Text] [Related]
18. Relationship between danofloxacin PK/PD parameters and emergence and mechanism of resistance of Mycoplasma gallisepticum in In Vitro model.
Zhang N; Wu Y; Huang Z; Zhang C; Zhang L; Cai Q; Shen X; Jiang H; Ding H
PLoS One; 2018; 13(8):e0202070. PubMed ID: 30157201
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial susceptibility and genetic profile of Mycoplasma hyopneumoniae isolates from Brazil.
Gonzaga NF; de Souza LFL; Santos MR; Assao VS; Rycroft A; Deeney AS; Fietto JLR; Bressan GC; Moreira MAS; Silva-Júnior A
Braz J Microbiol; 2020 Mar; 51(1):377-384. PubMed ID: 31797326
[TBL] [Abstract][Full Text] [Related]
20. In vitro development of resistance to enrofloxacin, erythromycin, tylosin, tiamulin and oxytetracycline in Mycoplasma gallisepticum, Mycoplasma iowae and Mycoplasma synoviae.
Gautier-Bouchardon AV; Reinhardt AK; Kobisch M; Kempf I
Vet Microbiol; 2002 Aug; 88(1):47-58. PubMed ID: 12119137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
